药物输送
癌症治疗
药品
DNA
纳米技术
医学
癌症
材料科学
生物医学工程
药理学
内科学
化学
生物化学
作者
Congcong Li,Mengzhen Wang,Peifeng Li,Josephine Juin-Jye Sheng,Qinrui Fu
出处
期刊:Small
[Wiley]
日期:2024-02-20
标识
DOI:10.1002/smll.202306257
摘要
Abstract Due to the disadvantages of poor targeting, slow action, and low effectiveness of current commonly used cancer treatments, including surgery, chemotherapy, and radiotherapy, researchers have turned to DNA as a biomaterial for constructing drug delivery nanocarriers. DNA is favored for its biocompatibility and programmability. In order to overcome the limitations associated with traditional drug delivery systems (DDSs), researchers have developed smart‐responsive DNA DDSs that can control drug release in response to specific physical or chemical stimuli at targeted sites. In this review, a summary of multiple targeted ligand structures is provided, various shapes of stable DNA nanomaterials, and different stimuli‐responsive drug release strategies in DNA DDSs. Specifically, targeted cell recognition, in vivo stable transport, and controlled drug release of smart DDSs are focused. Finally, the further development prospects and challenges of clinical application of DNA nanomaterials in the field of smart drug delivery are discussed. The objective of this review is to enhance researchers' comprehension regarding the potential application of DNA nanomaterials in precision drug delivery, with the aim of expediting the clinical implementation of intelligent DDSs.
科研通智能强力驱动
Strongly Powered by AbleSci AI